Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

Patients with advanced solid tumors refractory to and progressing after conventional therapies were treated with three different regimens of low-dose cyclophosphamide (CP) in combination with oncolytic adenovirus. CP was given with oral metronomic dosing (50 mg/day, N = 21), intravenously (single 1,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Cerullo, Vincenzo, Diaconu, Iulia, Kangasniemi, Lotta, Rajecki, Maria, Escutenaire, Sophie, Koski, Anniina, Romano, Valentina, Rouvinen, Noora, Tuuminen, Tamara, Laasonen, Leena, Partanen, Kaarina, Kauppinen, Satu, Joensuu, Timo, Oksanen, Minna, Holm, Sirkka-Liisa, Haavisto, Elina, Karioja-Kallio, Aila, Kanerva, Anna, Pesonen, Sari, Arstila, Petteri T, Hemminki, Akseli
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3182348/
https://ncbi.nlm.nih.gov/pubmed/21673660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados